Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance

Immunological Reviews

Volumn 272, Issue 1, 2016, Pages 8-16

  Starck, Shelley R ^a,b   Shastri, Nilabh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NGM Biopharmaceuticals Inc   (United States)

Author keywords

antigen presentation; antigen processing; cytotoxic T cells; major histocompatibility complex; protein synthesis

Indexed keywords

CELL PROTEIN; CRYPTIC PEPTIDE; DNA FRAGMENT; GENOMIC DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PEPTIDE; TRANSFER RNA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CD8+ T LYMPHOCYTE; CELL FUNCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE EVASION; IMMUNOSURVEILLANCE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN SYNTHESIS; READING FRAME; REVIEW; RNA TRANSLATION; START CODON; TRANSLATION INITIATION; TRANSLATIONAL READING FRAME;

EID: 84975476964     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12434     Document Type: Review

References (83)

1. Granados DP, Laumont CM, Thibault P, Perreault C. The nature of self for T cells-a systems-level perspective. Curr Opin Immunol 2015;34:1–8.
2. Shastri N, Cardinaud S, Schwab SR, Serwold T, Kunisawa J. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol Rev 2005;207:31–41.
3. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989;7:601–624.
4. Rock KL, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994;78:761–771.
5. Rock KL, York IA, Saric T, Goldberg AL. Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol 2002;80:1–70.
6. Monaco JJ. A molecular model for MHC class I-restricted antigen processing. Immunol Today 1992;13:173–179.
7. Kelly A, et al. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 1992;355:641–644.
8. Lehner PJ, Cresswell P. Processing and delivery of peptides presented by MHC class I molecules. Curr Opin Immunol 1996;8:59–67.
9. Raghavan M, Del Cid N, Rizvi SM, Peters LR. MHC class I assembly: out and about. Trends Immunol 2008;29:436–443.
10. Reits EA, Vos JC, Gromme M, Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000;404:774–778.
11. Schubert U, et al. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA 2000;97:13057–13062.
12. Yewdell JW, Anton LC, Bennink JR. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol 1996;157:1823–1826.
13. Yewdell JW, Nicchitta CV. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol 2006;27:368–373.
14. Farfan-Arribas DJ, Stern LJ, Rock KL. Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides. Proc Natl Acad Sci USA 2012;109:16998–17003.
15. Rock KL, Farfan-Arribas DJ, Colbert JD, Goldberg AL. Re-examining class-I presentation and the DRiP hypothesis. Trends Immunol 2014;35:144–152.
16. Shastri N, Schwab S, Serwold T. Producing nature's gene-chips. The generation of peptides for display by MHC class I molecules. Annu Rev Immunol 2002;20:463–493.
17. Ho O, Green WR. Alternative translational products and cryptic T cell epitopes: expecting the unexpected. J Immunol 2006;177:8283–8289.
18. Starck SR, Shastri N. Non-conventional sources of peptides presented by MHC class I. Cell Mol Life Sci 2011;68:1471–1479.
19. Laumont CM, et al. Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames. Nat Commun 2016;7:10238.
20. Boon T, Van Pel A. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 1989;29:75–79.
21. Gooding LR, O'Connell KA, Geib RW, Pipas JM. Cytotoxic T cell recognition of the SV40 Tumor antigen: a note of caution. In: Pernis B, Silverstein S, Vogel H eds. Processing and presentation of antigens. New York: Academic Press, 1988:87–95.
22. Fetten JV, Roy N, Gilboa E. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. J Immunol 1991;147:2697–2705.
23. Malarkannan S, Afkarian M, Shastri N. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. J Exp Med 1995;182:1739–1750.
24. Malarkannan S, Horng T, Shih PP, Schwab S, Shastri N. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 1999;10:681–690.
25. Schwab SR, Li KC, Kang C, Shastri N. Constitutive display of cryptic translation products by MHC class I molecules. Science 2003;301:1367–1371.
26. Schwab SR, Shugart JA, Horng T, Malarkannan S, Shastri N. Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol 2004;2:1774–1784.
27. Mayrand SM, Schwarz DA, Green WR. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus. J Immunol 1998;160:39–50.
28. Ho O, Green WR. Cytolytic CD8+ T cells directed against a cryptic epitope derived from a retroviral alternative reading frame confer disease protection. J Immunol 2006;176:2470–2475.
29. Maness NJ, et al. AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape. J Exp Med 2007;204:2505–2512.
30. Cardinaud S, et al. Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J Exp Med 2004;199:1053–1063.
31. Maness NJ, et al. Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope. J Immunol 2010;184:67–72.
32. Garrison KE, et al. Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin Vaccine Immunol 2009;16:1369–1371.
33. Berger CT, et al. Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J Exp Med 2010;207:61–75.
34. Bansal A, et al. CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription. J Exp Med 2010;207:51–59.
35. Champiat S, et al. Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. PLoS ONE 2012;7:e39311.
36. Bansal A, et al. Enhanced recognition of HIV-1 cryptic epitopes restricted by HLA class I salleles associated with a favorable clinical outcome. J Acquir Immune Defic Syndr 2015;70:1–8.
37. Goodenough E, et al. Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3’ UTR. Proc Natl Acad Sci USA 2014;111:5670–5675.
38. Li C, et al. Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proc Natl Acad Sci USA 2009;106:10770–10774.
39. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000;404:770–774.
40. Levitskaya J, et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995;375:685–688.
41. Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 1997;94:12616–12621.
42. Davenport MG, Pagano JS. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol 1999;73:3154–3161.
43. Kwun HJ, da Silva SR, Shah IM, Blake N, Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J Virol 2007;81:8225–8235.
44. Dolan BP, Bennink JR, Yewdell JW. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci 2011;68:1481–1489.
45. Cardinaud S, Starck SR, Chandra P, Shastri N. The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS ONE 2010;5:e8692.
46. Weinzierl AO, et al. A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays. Cancer Res 2008;68:2447–2454.
47. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987;196:947–950.
48. Kozak M. Pushing the limits of the scanning mechanism for initiation of translation. Gene 2002;299:1–34.
49. Hershey JWB, Merrick WC. The pathway and mechanism of initiation of protein synthesis. In: Sonenberg N, Hershey JWB, Mathews MB eds. Translational Control of Gene Expression. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2000:33–88.
50. Pestova TV, Hellen CU. The structure and function of initiation factors in eukaryotic protein synthesis. Cell Mol Life Sci 2000;57:651–674.
51. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 2005;6:318–327.
52. Piccirillo CA, Bjur E, Topisirovic I, Sonenberg N, Larsson O. Translational control of immune responses: from transcripts to translatomes. Nat Immunol 2014;15:503–511.
53. Suzuki Y, et al. Statistical analysis of the 5’ untranslated region of human mRNA using ‘Oligo-Capped’ cDNA libraries. Genomics 2000;64:286–297.
54. Rogozin IB, Kochetov AV, Kondrashov FA, Koonin EV, Milanesi L. Presence of ATG triplets in 5’ untranslated regions of eukaryotic cDNAs correlates with a ‘weak’ context of the start codon. Bioinformatics 2001;17:890–900.
55. Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 2009;324:218–223.
56. Ingolia NT, Lareau LF, Weissman JS. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 2011;147:789–802.
57. Olexiouk V, Crappe J, Verbruggen S, Verhegen K, Martens L, Menschaert G. sORFsorg: a repository of small ORFs identified by ribosome profiling. Nucleic Acids Res 2016;44:D324–D329.
58. Ingolia NT, et al. Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. Cell Rep 2014;8:1365–1379.
59. Starck SR, et al. Translation from the 5’ untranslated region shapes the integrated stress response. Science 2016;351:aad3867.
60. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011;334:1081–1086.
61. Rosenberg SA, et al. Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy. J Immunol 2002;168:2402–2407.
62. Graddis TJ, Diegel ML, McMahan CJ, Tsavler L, Laus R, Vidovic D. Tumor immunotherapy with alternative reading frame peptide antigens. Immunobiology 2004;209:535–544.
63. Tykodi SS, et al. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clin Cancer Res 2008;14:5260–5269.
64. Bullock TNJ, Eisenlohr LC. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J Exp Med 1996;184:1319–1329.
65. Saulquin X, et al. +1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. J Exp Med 2002;195:353–358.
66. Zook MB, Howard MT, Sinnathamby G, Atkins JF, Eisenlohr LC. Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. J Immunol 2006;176:6928–6934.
67. Hinnebusch AG, Dever TE, Asano K. Chapter 9: Mechanism of Translation Initiation in the Yeast Saccharomyces cerevisiae. Cold Spring Harbor, NY: Harbor Laboratory Press, 2007.
68. Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci USA 2004;101:11269–11274.
69. Skabkin MA, Skabkina OV, Hellen CU, Pestova TV. Reinitiation and other unconventional posttermination events during eukaryotic translation. Mol Cell 2013;51:249–264.
70. Lee S, Liu B, Lee S, Huang SX, Shen B, Qian SB. Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution. Proc Natl Acad Sci USA 2012;109:E2424–E2432.
71. Stern-Ginossar N, et al. Decoding human cytomegalovirus. Science 2012;338:1088–1093.
72. Arias C, et al. KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog 2014;10:e1003847.
73. Garcia MA, et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 2006;70:1032–1060.
74. Nemeth AL, et al. Unconventional translation initiation of human trypsinogen 4 at a CUG codon with an N-terminal leucine. A possible means to regulate gene expression. FEBS J 2007;274:1610–1620.
75. Liang H, et al. PTENalpha, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism. Cell Metab 2014;19:836–848.
76. Ingolia NT. Ribosome profiling: new views of translation, from single codons to genome scale. Nat Rev Genet 2014;15:205–213.
77. Wilson JE, Pestova TV, Hellen CUT, Sarnow P. Initiation of protein synthesis from the A site of the ribosome. Cell 2000;102:511–520.
78. Sasaki J, Nakashima N. Methionine-independent initiation of translation in the capsid protein of an insect RNA virus. Proc Natl Acad Sci USA 2000;97:1512–1515.
79. Pisarev AV, Shirokikh NE, Hellen CU. Translation initiation by factor-independent binding of eukaryotic ribosomes to internal ribosomal entry sites. C R Biol 2005;328:589–605.
80. Aranda M, Maule A. Virus-induced host gene shutoff in animals and plants. Virology 1998;243:261–267.
81. Andreev DE, et al. Translation of 5’ leaders is pervasive in genes resistant to eIF2 repression. Elife 2015;4:e03971.
82. Starck SR, et al. A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS ONE 2008;3:e3460.
83. Starck SR, et al. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 2012;336:1719–1723.